Skye Bioscience (SKYE) Notes Payables (2013 - 2020)
Skye Bioscience (SKYE) posted Notes Payables of $71,102 for Q3 2020, up 37.7% from the prior quarter.
Powered by 
Analysis
Skye Bioscience (SKYE) Notes Payables (2013 - 2020) Analysis & Trends
At the end of FY2013, Skye Bioscience's Notes Payables came in at $47,238.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn |
| 10 | Skye Bioscience | 7.90 Mn | -80.32 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2020 | 71,102.00 |
| Jun 30, 2020 | 51,653.00 |
| Apr 30, 2014 | 35,355.00 |
| Oct 31, 2013 | 47,238.00 |
| Jul 31, 2013 | 52,523.00 |
| Apr 30, 2013 | 41,149.00 |
API Access
Skye Bioscience Notes Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=notes-payables&ticker=SKYE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "notes-payables", "ticker": "SKYE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=notes-payables&ticker=SKYE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();